Cell Therapy
Our Expertise
We provide end-to-end bioanalytical support for adoptive cell therapies, including:
Targeted NGS panels, tumor profiling and mutational burden measurement
Precise measurement of specific T- or B-cell responses
Cellular target analysis, T-cell activation, and CRS monitoring
Predictive biomarker assays, RNA expression profiling, gene persistence & virus safety testing
Ligand-binding and immunoassay solutions for tracking drug activity and immune response
Gene expression, vector copy number (VCN), and replication-competent virus testing (RCL/RCR)
Expert Solutions for Complex Drug Development Challenges
With 40+ advanced technology platforms, we deliver unmatched flexibility and scalability. Our GCLP-compliant operations ensure regulatory-ready data, while integrated project management and high-throughput capacity keep your timelines on track.
Why Leading Biopharma Companies Rely on Eurofins
-
Regulatory-Compliant Methods aligned with FDA and EMA guidelines
-
Tailored Assay Design based on your therapeutic’s mechanism of action
-
End-to-End Support from early-phase development through commercialization
-
Rapid Turnaround and Scalable Solutions for complex clinical programs
Ready to Accelerate Your Cell Therapy Program?
